Q3 2024 OTC Markets Group Inc Earnings Call Transcript
Key Points
- Gross revenues grew by 1% and net revenue by 2% compared to the third quarter of 2023.
- OTC Link experienced significant growth, with a 16% increase in the third quarter.
- The company announced the launch of OTC Overnight, expanding trading hours and accessibility.
- A special dividend of $1.50 and a quarterly dividend of $0.18 per share were declared, reflecting strong shareholder returns.
- The company is focusing on integrating teams and consolidating technology platforms to drive operational efficiencies.
- Market data revenue licensing decreased by 1%, and corporate services revenue decreased by 2%.
- The corporate services business was impacted by a reduced number of subscribers, particularly in the OTCQB market.
- Revenues from EDGAR Online decreased by 15% due to subscriber cancellations.
- Pro user and non-pro user revenues in the market data licensing business decreased by 6% and 7%, respectively.
- Operating expenses grew by approximately 1% during the first nine months of the year, with compensation and benefits being a significant cost.
Good day. And thank you for standing by. Welcome to the OTC Markets Group third-quarter 2024 earnings conference call and webcast. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Dan Zinn, General Counsel and Chief of Staff.
Thank you, operator. Good morning and welcome to the OTC Markets Group third-quarter 2024 earnings conference call. With me today are Cromwell Coulson, our President and Chief Executive Officer; and Antonia Georgieva, our Chief Financial Officer.
Today's call will be accompanied by a slide presentation. Our earnings press release and the presentation are each available on our website. Certain statements during this call and in our presentation may relate to future events or expectations and as such may constitute forward-looking statements. Actual results may differ materially from these forward-looking statements. Information concerning risks and uncertainties that may impact our actual results is contained in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
